Internal Medicine

NEW DRUG: Lyvdelzi for primary biliary cholangitis
Get the info you need on this new product, part of our drug news roundup for February.
QUIZ: Got the nerve to test your peripheral neuropathy knowledge?
Damage to peripheral nerves affects around 1% of adults worldwide, according to a recent review. See how much you know about the causes, diagnosis and treatment of this common problem.

Be aware that ACEIs can occasionally cause small-bowel angioedema

Angiotensin-converting enzyme inhibitors (ACEIs) can induce small-bowel angioedema, leading to symptoms of abdominal pain, nausea, vomiting and diarrhea.
How to manage care of infants after urinary tract dilation is detected on prenatal/antenatal ultrasound

A new Canadian Pediatric Society practice point outlines a clinical pathway physicians can follow for these newborns.
Some natural health products may increase the risk of hepatotoxicity

Health Canada provides an overview of natural health products linked with rare cases of hepatotoxicity and how to counsel patients about this potential risk.
How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker

Blood vessel damage from fatty and high-sugar diets leads to inflammation, which can be detected by measuring C-reactive protein.
What is the EAT-Lancet diet?

Adopting the EAT-Lancet diet, which promotes vegetables and fruit but limits red meat, may help fend off kidney disease.
SGLT2 inhibitors vs. GLP-1 agonists for kidney outcomes in patients with type 2 diabetes

Study compares the effectiveness of SGLT2i and GLP-1RA treatment for acute and chronic kidney outcomes in patients with type 2 diabetes.
Tirzepatide versus dulaglutide cardiovascular outcomes in type 2 diabetes

Study compares cardiovascular outcomes of weekly tirzepatide versus dulaglutide in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Skin disease or CVD? New paper explores the interplay and highlights connections clinicians should recognize

The two are more closely connected than you might think.

NEW DRUG: Lyvdelzi for primary biliary cholangitis

QUIZ: Got the nerve to test your peripheral neuropathy knowledge?

Be aware that ACEIs can occasionally cause small-bowel angioedema

How to manage care of infants after urinary tract dilation is detected on prenatal/antenatal ultrasound

Some natural health products may increase the risk of hepatotoxicity

How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker

What is the EAT-Lancet diet?

SGLT2 inhibitors vs. GLP-1 agonists for kidney outcomes in patients with type 2 diabetes

Tirzepatide versus dulaglutide cardiovascular outcomes in type 2 diabetes

Skin disease or CVD? New paper explores the interplay and highlights connections clinicians should recognize